Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesis is that an antipsychotic drug combination of low-dose olanzapine
plus low-dose trifluoperazine is similar to regular-dose olanzapine monotherapy in efficacy
and safety for treatment of schizophrenia.The goal of this study is to compare the efficacy
and safety of the olanzapine (10 mg/d) and olanzapine (5 mg/d) plus trifluoperazine (5 mg/d)
in the treatment of acute psychotic exacerbations of schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Kaohsiung Kai-Suan Psychiatric Hospital
Collaborator:
Department of Health, Executive Yuan, R.O.C. (Taiwan)